United States · 
What does HealthCare Ventures invest in?
HealthCare Ventures invests most often at Series B and Series C (55% of the rounds on record), in sectors such as Healthcare, Home Services and Recruiting.
HealthCare Ventures highlights
- 01
70 rounds on record
- 02
Mostly Series B and Series C: 55% of its rounds
- 03
Sole investor in 2 rounds, median $8.0M
- 04
11 exits from the portfolio
What they do
- Type
- Growth equity (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- HealthcareHome ServicesRecruiting
- Based in
- Princeton, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first70 appearances
- 2015
1 round
- Sept
- 2014
1 round
- Jun
- 2013
4 rounds
- Oct
- Apr
- Mar
- Feb
- 2012
3 rounds
- Jun
- Mar
- Feb
- 2011
11 rounds
- Dec
- Nov
- Nov
- Nov
- Sept
- Aug
- Aug
- Jul
- Jul
- Jun
- Feb
- 2010
8 rounds
- Oct
- Sept
- Aug
- Aug
- Jul
- Jun
- Mar
- Mar
- 2009
6 rounds
- Nov
- Oct
- Jul
- Jun
- Jun
- Mar
- 2008
4 rounds
- Dec
- Nov
- Aug
- Mar
- 2007
8 rounds
- Nov
- Nov
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration5 named
DPDavid PaltzikPromoteriFiling they signed
HRHarold Robert WernerMemberiForm ADV
JHJames Henry CavanaughMemberiForm ADV
JWJohn Walter LittlechildMemberiForm ADV
MKMarla Kay McmillanVice President of FinanceiForm ADV
We also hold 10 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$5.1Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- HCV Management VIII, LLC
- SEC number
- CRD 163510
Exits from the portfolio
Companies it backed that were later bought or listed11 in all
Seahorse BioscienceBought by Agilent Technologies$235MSept 2015
RedPath Integrated PathologyBought by PDI,Inc.UndisclosedNov 2014
SkinMedicaBought by AllerganUndisclosedNov 2012
CardiokineBought by Cornerstone TherapeuticsUndisclosedJan 2012
Foldrx PharmaceuticalsBought by PfizerUndisclosedSept 2010
RedPath Integrated PathologyBought by ExonHit Therapeutics$32MApr 2010
BioProcessorsBought by Seahorse BioscienceUndisclosedMar 2009
ReplidyneBought by Cardiovascular SystemsUndisclosedFeb 2009
Xanthus PharmaceuticalsBought by AntisomaUndisclosedMay 2008
Critical Therapeutics,Inc.Bought by Cornerstone TherapeuticsUndisclosedMay 2008
An exit counts when it came after the firm's first round in the company. From historical deal records.